iarjmsIARJMSIARJMS2708-3594https://doi.org/10.47310/iarjms.2023.v04i01.039Prevelence of Diabetic Peripheral Neuropathy Using Michigan Neuropathy Screening Instrument in Semi-Urban Population of South IndiaSandeepGG. M.PrakashRahulReddyRajulaSumaD.Department of General Medicine, TOMCH and RC, The Oxford Medical College Hospital and Research Center, Bangalore, Karnataka, IndiaBackground: Diabetes represents a significant global public health burden. DPN is a microvascular complication of T2DM attributed to chronic hyperglycaemia, defined as the presence of peripheral nerve dysfunction in diabetics after exclusion of other causes. Screening for DPN in the clinical practice using a simple objective tool is essential. The Aim of the study was to determine the proportion of peripheral neuropathy in patients with Type 2 diabetes mellitus using Michigan Neuropathy Screening Instrument and comparison with other screening methods. Method: A cross sectional study is conducted among type 2 diabetes mellitus patients attending OPD and In-patients in a Tertiary Care Hospital. Study is conducted using detailed clinical examination and Michigan Neuropathy Screening Instrument (MNSI) which includes a pre-tested, pre-designed questionnaire and clinical examination, used to assess distal symmetrical polyneuropathy. Result: Among the 100 patients 54 are males and 46 are females. The mean duration of DM is 9.42±4.28 years. Based on clinical examination and MNSI Overall, 51% were found to have DPN. Based on the scoring of MNSI patient version, 39% patients have DPN. Whereas based on MNSI examination version 46% patients have DPN. Out of 100, patients who have HbA1c >6.5%, increasing age and diabetes duration of >5years are found to have higher proportion of DPN with a significant p value (<0.05).